LU-125950

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameLU-125950
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTopoisomerase (DNA) II alpha inhibitors
TargetsTopoisomerase (DNA) II alpha
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSpain
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbbott Gmbh & Co Kg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott Gmbh & Co Kg
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A